THOMAS BRISCOE: Open Payments
NPI 1992796189 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,437 in 128 payments from 21 companies in 2025. Trend: 2023 $3,295 · 2024 $3,593 · 2025 $2,437
Food & beverage: $2,355Education: $82
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $510 |
| Lilly USA, LLC | 16 | $359 |
| Janssen Biotech, Inc. | 9 | $241 |
| GENZYME CORPORATION | 9 | $232 |
| Arcutis Biotherapeutics, Inc. | 8 | $178 |
| E.R. Squibb & Sons, L.L.C. | 12 | $141 |
| Novartis Pharmaceuticals Corporation | 5 | $127 |
| LEO Pharma Inc. | 5 | $101 |
| Galderma Laboratories, L.P. | 6 | $100 |
| REVANCE THERAPEUTICS, INC. | 2 | $75 |
Products named: TALTZ, SKYRIZI, TREMFYA, RINVOQ, DUPIXENT, Zoryve, Sotyktu, NEMLUVIO.
Industry payments across LA — which companies pay providers there.
